Cite
HARVARD Citation
D'Arena, G. et al. (n.d.). Anti-CD44 mAb for the treatment of B-cell chronic lymphocytic leukemia and other hematological malignancies: evaluation of WO2013063498. Expert opinion on therapeutic patents. pp. 821-828. [Online].